For Atto 488 ADA synthesis (Fig. S8) 
6-amino-9-(2-((4-((2-amino-2-carboxyethyl)amino)-4-oxobutyl) (methyl)carbamoyl)phenyl)-4,5-disulfo-3H-xanthen-3-iminium
To a stirring solution of Atto 488 NHS ester (Atto 488 NHS, 5 mg, 0.0073 mmol) in DMF (anhydrous, 0.107 mL) was added Boc-D-Dap (1.5 mg, 0.0073 mmol, 1 equiv). DIEA (1.34 µL) was then added via a micropipette. The reaction mixture was stirred at room temperature for 16 h. The reaction mixture was concentrated in vacuo and the crude residue was treated with TFA:DCM (10 mL of 1:1) for 2 h.
The crude product was concentrated in vacuo, purified via reverse-phase HPLC (10-90% acetonitrile over 50 min), and lyophilized to yield the desired product as a dark red solid (1.3 mg, 23% yield, 0.0016 mmol, TFA salt). Apparent inseparable isomers (~3:1), major isomer reported: 1 
N6-(2-(7-amino-4-methyl-2-oxo-6-sulfo-2H-chromen-3-yl)acetyl)-D-lysine
To a stirring solution of Alexa Flour 350 NHS ester (AF 350 NHS, 5 mg, 0.012 mmol) in DMF (anhydrous, 0.12 mL) was added Boc-D-Lys (4.2 mg, 0.017 mmol, 1.4 equiv). DIEA (10 µL) was then added via a micropipette. The reaction mixture was stirred at room temperature for 16 h. The reaction mixture was concentrated in vacuo and the crude residue was then stirred in TFA:DCM (10 mL of 1:1) for 2 h. The crude product was concentrated in vacuo, purified via reverse-phase HPLC (10-50% acetonitrile over 20 min), and lyophilized to yield the desired product as a white solid (3. The following procedure was adapted from previously published literature (1) . To a stirring solution of substrate (19.68 g, 89.8 mmol) in a DCM/DMF mixture (28.0 mL DMF, ~150 mL DCM) at 0 °C was slowly added POCl3 (10.0 mL, 107.3 mmol). The reaction was allowed to warm to room temperature.
The reaction was quenched with cold water followed by the addition of NaHCO 3 (saturated). The resulting crude mixture was extracted with EtOAc and washed with brine, dried over sodium sulfate, and concentrated in vacuo. The resulting crude product was then separated by column chromatography (1:4 EtOAc/Hexane) to provide an off-white solid (Atto 610-P1, 6.16 grams, 24.9 mmol, 28% yield). 1 
Methyl 3-(6-(hydroxymethyl)-3,4-dihydroquinolin-1(2H)-yl)propanoate (Atto 610-P2):
To a stirring solution of Atto 610-P1 (4.34 g, 17.6 mmol) in MeOH (100 mL) at room temperature was added a tablet of NaBH4 (1 g, 26.4 mmol). After 35 min, an additional tablet of NaBH4 (1 g, 26.4 mmol) was added. After an additional 45 min, the reaction was quenched by the addition of acetone. The crude reaction mixture was then concentrated in vacuo. The resulting crude mixture was diluted in brine and EtOAc. The product was extracted with EtOAc and washed with brine. The organic layer was dried over sodium sulfate and concentrated in vacuo. The resulting pink oil product (Atto 610-P2), which degrades quickly, was carried onto the next reaction without further purification (3.96 g, 15.9 mmol, 91% yield).
Atto610 Methyl Propanoate (Atto 610-P3):
To a stirring solution of Atto 610-P2 (1.97 g, 7.48 mmol) and N,N-dimethyl-3-(prop-1-en-2-yl)aniline (1.29 g, 8.00 mmol) in DCM (16 mL) at 0 C was added boron trichloride. The reaction was allowed to continue at 0 C for 1 h. The reaction was then allowed to warm to room temperature.
After an additional hour of reacting, H2SO4 (40 mL, concentrated) was carefully added and DCM was removed in vacuo. This reaction was allowed to continue for an additional 2 h. A copious amount of ethanol (~500 mL) was added followed by the addition of (nBu) 4 NIO 4 (0.8 g, 1.80 mmol). The reaction was then refluxed for 10 min. The reaction was then allowed to cool to room temperature and stir overnight. The crude mixture was then concentrated in vacuo and the product was extracted with several portions of DCM. The crude product was purified by reverse phase HPLC (10-90% ACN/H2O over 20 min) to provide a blue powdery solid TFA salt (close to 1:1 mixture of ethyl ester and methyl ester, 0.926 g, 1.84 mmol, 25%). For the ethyl ester compound: 1 An acidic solution (THF/H20/HClconc, 12:8:4.6, 24.6mL) was added to sulfonated BODIPY FL ethyl ester (153 mg, 0.36 mmol). After stirring the reaction overnight, the crude mixture was concentrated in vacuo. The product was purified by reverse-phase HPLC (10-90% acetonitrile over 10 min), and lyophilized to yield the desired product as a red solid (61.6 mg, 43% yield). 1 To a stirring solution of sulfonated BODIPY FL (109.7 mg, 0.28 mmol) in DMF (anhydrous, 3 mL) was added CDI (55.5 mg, 0.34 mmol, 1.2 equiv.). After 2 h of acid activation, Boc-D-Dap was added in one portion (68.6 mg, 0.34 mmol, 1.2 equiv.) and the reaction continued overnight. The crude residue was then stirred in TFA:DCM (10 mL of 1:1) for 1 h at room temperature. The crude product was concentrated in vacuo, purified by reverse-phase HPLC (10-90% acetonitrile over 10 min) and lyophilized to yield the desired product as a red solid (50.8 mg, 38% yield, TFA salt). 1 For YADA synthesis (Fig. S14)   Potassium 6-amino-2-(2-amino-2-carboxyethyl)-1,3-dioxo-2,3-dihydro-1H 
SI-Methods of data acquisition
Culture growth. Strain characteristics and growth conditions are described in Table S2 For Cy3BADA and TDL STORM images in Fig. 4 , a reductive caging STORM protocol optimized for bacterial cell labeling was used (4). To exponentially growing E. coli imp4213 ∆6 Ldt cells grown in LB broth, 35 µg/ml cephalexin was added and the cultures were incubated for 2 h; cephalexin inhibits cell division and results in elongated cells. These cells were then pulsed with 1 mM Cy 3B ADA/TDL for 15 s-2 min and were immediately fixed by adding ice-cold EtOH to a final concentration of 70% and incubated on ice for 15 min. Cells were then transferred into a 1.7-mL tube and the cells were washed with ice-cold H2O twice (5 min, 9,000g). The cell pellet was resuspended in 300 µL freshly prepared NaBH4 (1 mg/mL, in H2O) and incubated in the dark at room temperature, leaving the cap of the tube open as H 2 gas formed. After 15 min, the redox reaction was quenched by adding 1 mL 10x PBS and the cell suspension was further incubated for 5 min at room temperature. The cells were then pelleted one final time, the cell pellet was resuspended in 5-10 µL 10x PBS, and 0.7 µL cells were spotted onto plasma-cleaned, poly-L-lysine coated coverslips and mounted with 2 µL Prolong Gold Antifade reagent. Reductive caging STORM imaging was performed within 30 min, as the reduced (i.e. dark) Cy 3B ADA and TDL can spontaneously re-oxidize over time.
Image sample preparation. 24x50 mm coverslips (#1.5) were used as imaging supports for the inverted microscope system. For fluorescence imaging, the slides were rinsed with ethanol and water twice, and air-dried before use. For STORM imaging, coverslips were plasma-cleaned. Cell samples were loaded onto the coverslips, followed by laying an 8x8 mm wide, 2-mm thick PBS-agar pad on top of the cells. The coverslip-pad combination was placed onto a customized slide holder on microscopes with the pad facing upwards.
Image acquisition. Phase/fluorescence images were acquired using a Nikon Ti-E inverted microscope equipped with a 1.4NA Plan Apo 60X oil objective and Andor iXon X3 EMCCD camera.
NIS-Elements AR software was used for image acquisition. Selection of light sources and filters for each FDAA is summarized in Tables 2 and S3 . Light source power, EM gain, and exposure time were optimized for each experiment/specimen.
A quantitative assessment of the brightness of FDAA labeling is difficult because it is dependent on growth conditions/durations, dye concentrations, bacterial species/strain, imaging conditions (excitation and emission filters, exposure times, gains, etc.). To ensure a high signal-to-background ratio of FDAA labeling, careful optimization of microscopy settings is recommended, including light source power, exposure, and imaging interval. One can also use antifade reagents to minimize photobleaching of FDAAs.
STORM images were acquired on a microscope built with a Ti-E Eclipse stand (Nikon Instruments, Inc., Melville, NY, USA). A Plan Apo Lambda 100X DM (NA 1.45) (Nikon) objective was used to acquire phase-contrast images concurrently with fluorescence images. CUBE diode 405-nm and Sapphire OPSL 561-nm lasers (Coherent, Santa Clara, CA, USA) were combined into an optical fibre attached to the microscope stand. A weak cylindrical lens was introduced into the imaging path to capture three-dimensional localization information using the astigmatism imaging method (5). Shuttering of laser illumination was controlled with an acousto-optic tuneable filter (AA optoelectronics, Orsay, France) before the fibre coupler. Images were acquired with an iXon3+ 887 EMCCD (Andor Technology, South Windsor, CT, USA) camera, and synchronisation between components was achieved using µ-Manager 1.4 (6) with a microcontroller (Arduino, Almuñécar, Spain). Fluorescence spectra and intensity acquisition. Spectra wavelengths and FDAA fluorescence intensities were measured using a SpectraMax M2 plate reader (Molecular Devices). 48/96-well plates (Falcon Polystyrene) and cuvettes (polymethyl methacrylate) were used based on the experimental design as described in each section.
For spectra measurements, FDAA stock solutions were diluted with 1x PBS (pH 7.4) to a final concentration of 0.05-0.1 mM. Absorbance spectra were obtained by scanning the samples with excitation light ranging from 300 to 900 nm with an increment of 1 nm using disposable cuvettes.
The wavelength at ~20 nm below the highest absorbance was used as the excitation wavelength for measuring excitation spectra. Excitation and emission spectra in Figs. 2 and S1 were generated using Prism. FDAA intensity was recorded in time-lapse during a continuous light exposure at the appropriate excitation wavelength (Table 2) for ~30 s. The RAM function of NIS-Elements AR software was used for the measurement. Exponential decay curves were generated using Prism. Please note that the decay curve of FDAA intensity is dependent on imaging conditions (e.g. the power of light source).
Measurement of distribution coefficient (LogD
Thus, the photo-stability values reported here should only be used when comparing FDAAs in this study.
FDAA intensity quantification in Table 3 was accomplished using the MicrobeJ plugin in FIJI (8) .
Cell morphologies and boundaries were defined using the phase channel. The fluorescence intensity of the cells (n>100) was then measured and averaged using the plugin. Table S2 : Bacterial species used in this study.
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